Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up Safety and Efficacy of PNEUMOSTEM in BPD
NCT01897987Phase 2Completed
- Sponsor
- MEDIPOST
- Start
- Jan 2014
- Primary completion
- Mar 2020
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of pneumostem in bronchopulmonary dysplasia (BPD), sponsored by MEDIPOST. Started Jan 2014; status: completed.
02
Drugs
pneumostem
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01897987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897987.